Thrombotic microangiopathy: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 1: Line 1:
*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction
*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction
{| class="wikitable"
*Primary
!Disease
**[[Thrombotic thrombocytopenia purpura]]
!Clinical Clues
**[[Hemolytic-uremic syndrome]]
|-
**[[Atypical hemolytic-uremic syndrome]]
! colspan="2" |Primary
**[[HELLP syndrome]]
|-
*Associated with coexisting condition
|[[Thrombotic thrombocytopenia purpura]]
**Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]]
|PT/INR and PTT are normal
**[[Drug-induced thrombotic microangiopathy]], including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition)
|-
**[[Sepsis]] and [[secondary hemolytic-uremic syndrome]] (usually from [[Streptococcus pneumoniae]] or [[influenza]])
|[[Hemolytic-uremic syndrome]]
**[[DIC]]
|PT/INR and PTT are normal
**[[Malignancy]]
|-
**[[HIV]]
|[[Atypical hemolytic-uremic syndrome]]

|PT/INR and PTT are normal
|-
|[[HELLP syndrome]]
|
|-
! colspan="2" |Secondary
|-
|Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]]
|
|-
|[[Drug-induced thrombotic microangiopathy]]
|including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition
|-
|[[Sepsis]]
|
|-
|[[Secondary hemolytic-uremic syndrome]]
|most commonly from [[Streptococcus pneumoniae]] or [[influenza]]
|-
|[[DIC]]
|PT/INR and PTT are prolonged
|-
|[[Malignancy]]
|
|-
|[[HIV]]
|
|}
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Thrombosis]]
[[Category:Thrombosis]]

Revision as of 11:25, 19 March 2024

Disease Clinical Clues
Primary
Thrombotic thrombocytopenia purpura PT/INR and PTT are normal
Hemolytic-uremic syndrome PT/INR and PTT are normal
Atypical hemolytic-uremic syndrome PT/INR and PTT are normal
HELLP syndrome
Secondary
Autoimmune disease, including systemic lupus erythematosus or antiphospholid antibody syndrome
Drug-induced thrombotic microangiopathy including quinine, ticlopidine, and chemotherapy (mitomycin, gemcitabine, cyclosporine, and tacrolimus, though it may also be caused by the underlying condition
Sepsis
Secondary hemolytic-uremic syndrome most commonly from Streptococcus pneumoniae or influenza
DIC PT/INR and PTT are prolonged
Malignancy
HIV